机译:NTRK2融合驱动的儿科胶质母细胞瘤:个性化肿瘤学用鉴定关键分子司机
University of British Columbia;
Canada’s Michael Smith Genome Sciences Centre;
Canada’s Michael Smith Genome Sciences Centre;
Department of Pathology New York University School of Medicine;
Department of Pathology New York University School of Medicine;
Canada’s Michael Smith Genome Sciences Centre;
Canada’s Michael Smith Genome Sciences Centre;
Canada’s Michael Smith Genome Sciences Centre;
Canada’s Michael Smith Genome Sciences Centre;
Division of Pediatric Hematology/Oncology BC Children’s Hospital;
Division of Pediatric Hematology/Oncology BC Children’s Hospital;
University of British Columbia;
Division of Pediatric Hematology/Oncology BC Children’s Hospital;
Division of Anatomic Pathology Children’s and Women’s Health Centre of BC;
机译:NTRK2融合驱动的儿科胶质母细胞瘤:个性化肿瘤学用鉴定关键分子司机
机译:确定中型儿科血液肿瘤门诊门诊患者经验的关键驱动因素
机译:基于病理类型的小儿脑肿瘤的驾驶基因和钥匙途径的鉴定及分子发病机制的比较
机译:胶质细胞瘤的辐射素:鉴定与分子亚型相关的射线组学
机译:在选择尾矿处理技术时,进行定性风险评估并确定要考虑的关键驱动因素。
机译:NTRK2融合驱动的儿科胶质细胞瘤:通过整合基因组和转录组分析鉴定致癌司机
机译:NTRK2融合驱动的儿科胶质母细胞瘤:鉴定个性化肿瘤学的关键分子司机